HMP Education

  • Inflammatory Bowel Diseases
  • Patient Preference

AIBD 2026

Describe the current understanding of IBD pathophysiology with respect to inflammatory signaling pathways and potential therapeutic targets Integrate clinical evidence, recent real-world data, current guidelines, and patient preferences into individualized treatment plans for IBD patients Assess the mechanism of action and therapeutic potential of evolving treatments in IBD Interpret clinical data for integration into the management of special patient populations in IBD

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 25.75 creditsAAPA Category 1 Credit™Up to 25.75 creditsAMA PRA Category 1 Credit™Up to 25.75 creditsNursingUp to 25.75 creditsPharmacyUp to 25.75 credits

MOC types

ABS — Accredited CMEUp to 25.75 points

FDA REMS

No

Qualifies for MIPS

No
Start Date
December 7, 2026
End Date
December 11, 2026

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Live
  • Credit · Up to 25.75 credits
  • MOC · Up to 25.75 points
  • Commercial Support
  • When
    Dec 7–10, 2026